Search research articles
Contact Us
Filters
Showing results (21-30 of 48) with videos related to
Page
of 5
Sort By:
Cancers
|
May 14, 2022
Genetic and Clinical Characteristics of <i>ARID1A</i> Mutated Melanoma Reveal High Tumor Mutational Load without Implications on Patient Survival
Carl Maximilian Thielmann, Johanna Matull, Sebastian Roth, et al.
International Journal of Molecular Sciences
|
March 25, 2022
The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition
Luca Hegedüs, Elisabeth Livingstone, Ágnes Bánkfalvi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 6, 2021
Sustainable responses in metastatic melanoma patients with and without brain metastases after elective discontinuation of anti-PD1-based immunotherapy due to complete response
Florentia Dimitriou, Anne Zaremba, Clara Allayous, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 27, 2021
Molecular pathology as a diagnostic aid in difficult-to-classify melanocytic tumours with spitzoid morphology
Anne Zaremba, Georg Lodde, Rajmohan Murali, et al.
Frontiers in Immunology
|
January 1, 2026
Extracorporeal photopheresis as a therapeutic approach for treatment resistant immune-related adverse events in anti-PD-1-treated melanoma patients
Carl Maximilian Thielmann, Johanna Andrea Seier, Lisa Schielke, et al.
Frontiers in Immunology
|
June 21, 2024
Clinical and genetic characteristics of <i>BAP1</i>-mutated non-uveal and uveal melanoma
Johanna Matull, Jan-Malte Placke, Georg Lodde, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 2, 2024
Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockade
Eleftheria Chorti, Bernd Kowall, Jessica C Hassel, et al.
International Journal of Cancer
|
June 23, 2022
Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors
Anne Zaremba, Philipp Jansen, Rajmohan Murali, et al.
Cancers
|
September 9, 2022
Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions
Anne Zaremba, Philipp Jansen, Rajmohan Murali, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 14, 2024
Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma
Lea Jessica Albrecht, Florentia Dimitriou, Piyush Grover, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 48) with videos related to
Sort By:
Page
of 5
Cancers
|
May 14, 2022
Genetic and Clinical Characteristics of <i>ARID1A</i> Mutated Melanoma Reveal High Tumor Mutational Load without Implications on Patient Survival
Carl Maximilian Thielmann, Johanna Matull, Sebastian Roth, et al.
International Journal of Molecular Sciences
|
March 25, 2022
The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition
Luca Hegedüs, Elisabeth Livingstone, Ágnes Bánkfalvi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 6, 2021
Sustainable responses in metastatic melanoma patients with and without brain metastases after elective discontinuation of anti-PD1-based immunotherapy due to complete response
Florentia Dimitriou, Anne Zaremba, Clara Allayous, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 27, 2021
Molecular pathology as a diagnostic aid in difficult-to-classify melanocytic tumours with spitzoid morphology
Anne Zaremba, Georg Lodde, Rajmohan Murali, et al.
Frontiers in Immunology
|
January 1, 2026
Extracorporeal photopheresis as a therapeutic approach for treatment resistant immune-related adverse events in anti-PD-1-treated melanoma patients
Carl Maximilian Thielmann, Johanna Andrea Seier, Lisa Schielke, et al.
Frontiers in Immunology
|
June 21, 2024
Clinical and genetic characteristics of <i>BAP1</i>-mutated non-uveal and uveal melanoma
Johanna Matull, Jan-Malte Placke, Georg Lodde, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 2, 2024
Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockade
Eleftheria Chorti, Bernd Kowall, Jessica C Hassel, et al.
International Journal of Cancer
|
June 23, 2022
Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors
Anne Zaremba, Philipp Jansen, Rajmohan Murali, et al.
Cancers
|
September 9, 2022
Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions
Anne Zaremba, Philipp Jansen, Rajmohan Murali, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 14, 2024
Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma
Lea Jessica Albrecht, Florentia Dimitriou, Piyush Grover, et al.
Page
of 5